Core Viewpoint - Recently, Fosun Pharma Industry Development (Chengdu) Co., Ltd. was established, focusing on medical research, drug testing instrument sales, and pharmaceutical equipment sales, fully owned by Fosun Pharma (600196) [2][3]. Company Information - The company is registered with a capital of 10 million RMB and has a business scope that includes medical research and experimental development, drug testing instrument sales, and sales of pharmaceutical specialized equipment [3]. - The legal representative is Yi Kexin, and the company is classified as a limited liability company with no fixed term of operation [3]. Business Scope - The general business activities include medical research and experimental development, drug testing instrument sales, pharmaceutical specialized equipment sales, packaging materials sales, and logistics services [3]. - The company is also involved in technology import and export, technical services, research and development, consulting, and technology transfer [3]. Regulatory Information - The company is registered with the Chengdu High-tech Zone Market Supervision Administration, and its business license is valid until July 30, 2025 [3].

Company Overview - 博媄生物科技（苏州）有限公司 has been established with a registered capital of 2 million RMB, fully owned by 西安博和医疗科技有限公司 [1] - The legal representative of the company is 罗惠娴 [1] Business Scope - The company’s business activities include technology services, development, consulting, and transfer, as well as sales of various medical devices and hygiene products [1] - Additional activities encompass retail and wholesale of cosmetics, daily chemical products, and information consulting services [1] Corporate Structure - 博媄生物科技 is classified as a limited liability company, specifically a法人独资 (wholly-owned by a legal entity) [1] - The company is located in 常熟市, 江苏省, within the 协同创新产业园 [1] Registration and Compliance - The company is registered with a business term extending until August 6, 2025, with no fixed expiration [1] - The registration authority is 常熟市数据局 [1]

Company Overview - Hubei Xueluo Food Technology Co., Ltd. has been established with a registered capital of 30 million RMB [1] - The legal representative of the company is Zhang Min, and it is wholly owned by Hubei Xueluo Enterprise Management Co., Ltd. [1] Business Scope - The company’s business scope includes technology services, development, consulting, exchange, transfer, promotion, agricultural scientific research, smart agriculture management, research and development of intelligent robots, park management services, and industrial engineering design services [1] - The company operates under the category of scientific research and technical services, specifically in engineering and technical research and experimental development [1] Registration Details - The company is registered with the market supervision administration of Qianjiang City, Hubei Province [1] - The business term is set from August 5, 2025, with no fixed expiration date [1] - The registered address is located at No. 21, Qianyuan Middle Road, Yujia Tai Community, Qianjiang City, Hubei Province [1]

天眼查商业履历信息显示，苏州苏试试验集团股份有限公司，成立于2007年，位于苏州市，是一家以从 事研究和试验发展为主的企业。企业注册资本50854.7806万人民币，实缴资本20608万人民币。公司法 定代表人为钟琼华。 金融界消息 截至2025年8月6日收盘，苏试试验（300416）报收于16.57元，上涨1.35%，换手率5.34%， 成交量26.96万手，成交金额4.45亿元。 资金流向方面，今日主力资金净流入5756.47万元，占比成交额12.93%。其中，超大单净流入1100.31万 元、占成交额2.47%，大单净流入4656.15万元、占成交额10.46%，中单净流出流入786.55万元、占成交 额1.77%，小单净流出6543.01万元、占成交额14.69%。 苏试试验最新一期业绩显示，截至2025中报，公司营业总收入9.91亿元、同比增长8.09%，归属净利润 1.17亿元，同比增长14.18%，扣非净利润1.14亿元，同比增长20.72%，流动比率1.714、速动比率 1.445、资产负债率42.02%。 通过天眼查大数据分析，苏州苏试试验集团股份有限公司共对外投资了26家企业，参与招投标项 ...

Group 1 - The stock price of Beifang Changlong (301357) closed at 157.9 yuan, an increase of 20.0% with a turnover rate of 54.13% and a trading volume of 128,800 hands, amounting to 1.892 billion yuan [1] - The net inflow of main funds today was 64.21 million yuan, accounting for 3.39% of the transaction amount, with large orders showing a net inflow of 83.52 million yuan [1] - The latest quarterly report shows total operating revenue of 20.569 million yuan, a year-on-year decrease of 16.86%, and a net profit attributable to shareholders of 5.0704 million yuan, a year-on-year decrease of 244.16% [1] Group 2 - Beifang Changlong New Material Technology Co., Ltd. was established in 2010 and is located in Xi'an, focusing on research and experimental development [2] - The company has made investments in 2 enterprises, participated in 29 bidding projects, and holds 25 trademark registrations and 145 patent registrations [2] - The company has a registered capital of 95.2 million yuan and a paid-in capital of 68 million yuan [1]

金融界消息 截至2025年8月5日收盘，圣诺生物（688117）报收于39.75元，下跌2.14%，换手率4.62%， 成交量7.28万手，成交金额2.89亿元。 资金流向方面，今日主力资金净流出3103.31万元，占比成交额10.73%。其中，超大单净流出2940.68万 元、占成交额10.17%，大单净流出162.63万元、占成交额0.56%，中单净流出流入897.03万元、占成交 额3.1%，小单净流入2206.28万元、占成交额7.63%。 天眼查商业履历信息显示，成都圣诺生物科技股份有限公司，成立于2001年，位于成都市，是一家以从 事研究和试验发展为主的企业。企业注册资本15738.5978万人民币，实缴资本5000万人民币。公司法定 代表人为文永均。 圣诺生物最新一期业绩显示，截至2025一季报，公司营业总收入1.84亿元、同比增长77.15%，归属净利 润4711.97万元，同比增长186.06%，扣非净利润4794.31万元，同比增长213.63%，流动比率1.216、速动 比率0.712、资产负债率41.96%。 通过天眼查大数据分析，成都圣诺生物科技股份有限公司共对外投资了11家企业，参 ...

Core Viewpoint - As of August 5, 2025, Qitian Technology (300061) reported a closing price of 12.68 yuan, experiencing a decline of 0.39% with a turnover rate of 2.37% and a trading volume of 146,800 hands, amounting to 186 million yuan in transaction value [1] Financial Performance - For the first quarter of 2025, Qitian Technology reported total operating revenue of 125 million yuan, a year-on-year decrease of 38.10% - The net profit attributable to shareholders was 2.83 million yuan, showing a year-on-year increase of 149.53% - The net profit excluding non-recurring items was 2.75 million yuan, reflecting a year-on-year growth of 135.96% - The current ratio stood at 1.542, the quick ratio at 1.538, and the debt-to-asset ratio at 57.92% [1] Company Overview - Qitian Technology Group Co., Ltd. was established in 1996 and is located in Shanghai, primarily engaged in research and experimental development - The company has a registered capital of 6.5899 billion yuan and a paid-in capital of 1.5565 billion yuan - The legal representative of the company is Li Tiansong [1] - According to data analysis, Qitian Technology has made investments in 13 enterprises, participated in 2 bidding projects, holds 71 trademark registrations, 8 patents, and possesses 23 administrative licenses [2]

来源：金融界 天眼查资料显示，中国石油化工股份有限公司，成立于2000年，位于北京市，是一家以从事石油和天然 气开采业为主的企业。企业注册资本12173968.9893万人民币。通过天眼查大数据分析，中国石油化工 股份有限公司共对外投资了263家企业，参与招投标项目5000次，财产线索方面有商标信息45条，专利 信息5000条，此外企业还拥有行政许可40个。 中石化（大连）石油化工研究院有限公司，成立于2022年，位于大连市，是一家以从事研究和试验发展 为主的企业。企业注册资本338459.08万人民币。通过天眼查大数据分析，中石化（大连）石油化工研 究院有限公司共对外投资了1家企业，参与招投标项目1173次，专利信息4657条，此外企业还拥有行政 许可58个。 金融界2025年8月5日消息，国家知识产权局信息显示，中国石油化工股份有限公司、中石化（大连）石 油化工研究院有限公司取得一项名为"一种催化柴油沸腾床加氢转化方法"的专利，授权公告号 CN117757518B，申请日期为2022年09月。 ...

上海徐工智能科技有限公司，成立于2000年，位于上海市，是一家以从事专业技术服务业为主的企业。 企业注册资本4500万人民币。通过天眼查大数据分析，上海徐工智能科技有限公司参与招投标项目1 次，专利信息97条。 来源：金融界 金融界2025年8月5日消息，国家知识产权局信息显示，江苏徐工工程机械研究院有限公司、徐州徐工矿 业机械有限公司、上海徐工智能科技有限公司取得一项名为"基于双向长短时记忆网络的燃料电池故障 诊断方法及装置"的专利，授权公告号CN119881674B，申请日期为2025年03月。 天眼查资料显示，江苏徐工工程机械研究院有限公司，成立于2018年，位于徐州市，是一家以从事研究 和试验发展为主的企业。企业注册资本50000万人民币。通过天眼查大数据分析，江苏徐工工程机械研 究院有限公司共对外投资了7家企业，参与招投标项目269次，专利信息2790条，此外企业还拥有行政许 可14个。 徐州徐工矿业机械有限公司，成立于2015年，位于徐州市，是一家以从事通用设备制造业为主的企业。 企业注册资本190000万人民币。通过天眼查大数据分析，徐州徐工矿业机械有限公司共对外投资了6家 企业，参与招投标项目 ...

来源：金融界 天眼查资料显示，如般量子科技有限公司，成立于2017年，位于北京市，是一家以从事科技推广和应用 服务业为主的企业。企业注册资本5000万人民币。通过天眼查大数据分析，如般量子科技有限公司共对 外投资了2家企业，财产线索方面有商标信息8条，专利信息296条。 南京如般量子科技有限公司，成立于2019年，位于南京市，是一家以从事研究和试验发展为主的企业。 企业注册资本500万人民币。通过天眼查大数据分析，南京如般量子科技有限公司专利信息164条，此外 企业还拥有行政许可5个。 金融界2025年8月5日消息，国家知识产权局信息显示，如般量子科技有限公司;南京如般量子科技有限 公司取得一项名为"基于数字货币的发送方离线抗量子计算交易方法及系统"的专利，授权公告号 CN114529274B，申请日期为2020年11月。 ...